{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:29:19Z","timestamp":1775093359800,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Biochemical suspicion of familial hypocalciuric hypercalcemia (FHH) might provide with a negative (FHH-negative) or positive (FHH-positive) genetic result. Understanding the differences between both groups may refine the identification of those with a positive genetic evaluation, aid management decisions and prospective surveillance. We aimed to compare FHH-positive and FHH-negative patients, and to identify predictive variables for FHH-positive cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Design<\/jats:title>\n                <jats:p>Retrospective, national multi-centre study of patients with suspected FHH and genetic testing of the <jats:italic>CASR<\/jats:italic>, <jats:italic>AP2S1<\/jats:italic> and <jats:italic>GNA11<\/jats:italic> genes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Clinical, biochemical, radiological and treatment data were collected. We established a prediction model for the identification of FHH-positive cases by logistic regression analysis and area under the ROC curve (AUROC) was estimated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We included 66 index cases, of which 30 (45.5%) had a pathogenic variant. FHH-positive cases were younger (<jats:italic>p<\/jats:italic>\u2009=\u20090.029), reported more frequently a positive family history (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), presented higher magnesium (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and lower parathormone levels (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and were less often treated for hypercalcemia (<jats:italic>p<\/jats:italic>\u2009=\u20090.017) in comparison to FHH-negative cases. Magnesium levels showed the highest AUROC (0.825, 95%CI: 0.709\u20130.941). The multivariate analysis revealed that family history and magnesium levels were independent predictors of a positive genetic result. The predictive model showed an AUROC of 0.909 (95%CI: 0.826\u20130.991).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The combination of magnesium and a positive family history offered a good diagnostic accuracy to predict a positive genetic result. Therefore, the inclusion of magnesium measurement in the routine evaluation of patients with suspected FHH might provide insight into the identification of a positive genetic result of any of the CaSR-related genes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-023-03560-y","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T09:02:33Z","timestamp":1705050153000},"page":"747-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical and outcome comparison of genetically positive vs. negative patients in a large cohort of suspected familial hypocalciuric hypercalcemia"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-8048","authenticated-orcid":false,"given":"Queralt","family":"Asla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0138-8217","authenticated-orcid":false,"given":"Helena","family":"Sard\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Segu\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Mart\u00ednez de Pinillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-7650","authenticated-orcid":false,"given":"Isabel","family":"Mazarico-Altisent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Capel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Rives","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"\u00c1vila-Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9645-3260","authenticated-orcid":false,"given":"Manuel","family":"Mu\u00f1oz Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignasi","family":"Saig\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-2476","authenticated-orcid":false,"given":"Nuria","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eul\u00e0lia","family":"Urgell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7052-6436","authenticated-orcid":false,"given":"Susan M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merc\u00e8","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Oriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5887-5016","authenticated-orcid":false,"given":"Mireia","family":"Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0301-9984","authenticated-orcid":false,"given":"Mireia","family":"Tondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-7114","authenticated-orcid":false,"given":"Anna","family":"Aulinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"3560_CR1","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2022.18331","volume":"328","author":"MD Walker","year":"2022","unstructured":"M.D. Walker, E. Shane, Hypercalcemia: a review. JAMA 328, 1624\u20131636 (2022). https:\/\/doi.org\/10.1001\/jama.2022.18331","journal-title":"JAMA"},{"key":"3560_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","volume":"32","author":"JY Lee","year":"2018","unstructured":"J.Y. Lee, D.M. Shoback, Familial hypocalciuric hypercalcemia and related disorders. Best Pract. Res. Clin. Endocrinol. Metab. 32, 609\u2013619 (2018). https:\/\/doi.org\/10.1016\/j.beem.2018.05.004","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"3560_CR3","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","volume":"106","author":"R Dershem","year":"2020","unstructured":"R. Dershem, C.M. Gorvin, R.P.R. Metpally et al. Familial hypocalciuric hypercalcemia type 1 and autosomal-dominant hypocalcemia type 1: Prevalence in a large healthcare population. Am. J. Hum. Genet. 106, 734\u2013747 (2020). https:\/\/doi.org\/10.1016\/j.ajhg.2020.04.006","journal-title":"Am. J. Hum. Genet"},{"key":"3560_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s002230001201","volume":"68","author":"J Hinnie","year":"2001","unstructured":"J. Hinnie, E. Bell, E. McKillop et al. The prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int. 68, 216\u2013218 (2001). https:\/\/doi.org\/10.1007\/s002230001201","journal-title":"Calcif Tissue Int"},{"key":"3560_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12020-017-1241-5","volume":"55","author":"A Szalat","year":"2017","unstructured":"A. Szalat, S. Shpitzen, A. Tsur et al. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia. Endocrine 55, 741\u2013747 (2017). https:\/\/doi.org\/10.1007\/s12020-017-1241-5","journal-title":"Endocrine"},{"key":"3560_CR6","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1210\/jc.2015-3442","volume":"101","author":"R Vargas-Poussou","year":"2016","unstructured":"R. Vargas-Poussou, L. Mansour-Hendili, S. Baron et al. Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: Similarities and differences. J. Clin. Endocrinol Metab. 101, 2185\u20132195 (2016). https:\/\/doi.org\/10.1210\/jc.2015-3442","journal-title":"J. Clin. Endocrinol Metab"},{"key":"3560_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.4158\/EP12284.RA","volume":"19","author":"MC Shinall Jr.","year":"2013","unstructured":"M.C. Shinall Jr., K.M. Dahir, J.T. Broome, Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism. Endocr. Pract. 19, 697\u2013702 (2013). https:\/\/doi.org\/10.4158\/EP12284.RA","journal-title":"Endocr. Pract."},{"key":"3560_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","volume":"69","author":"SE Christensen","year":"2008","unstructured":"S.E. Christensen, P.H. Nissen, P. Vestergaard et al. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin. Endocrinol (Oxf) 69, 713\u2013720 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03259.x","journal-title":"Clin. Endocrinol (Oxf)"},{"key":"3560_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.surg.2021.04.055","volume":"171","author":"SR Li","year":"2022","unstructured":"S.R. Li, K.L. McCoy, H.E. Levitt et al. Is routine 24-hour urine calcium measurement useful during the evaluation of primary hyperparathyroidism. Surgery 171, 17\u201322 (2022). https:\/\/doi.org\/10.1016\/j.surg.2021.04.055","journal-title":"Surgery"},{"key":"3560_CR10","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","volume":"186","author":"J Bollerslev","year":"2022","unstructured":"J. Bollerslev, L. Rejnmark, A. Zahn et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: Recommendations of the ESE educational program of parathyroid disorders. Eur. J. Endocrinol 186, R33\u2013R63 (2022). https:\/\/doi.org\/10.1530\/EJE-21-1044","journal-title":"Eur. J. Endocrinol"},{"key":"3560_CR11","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/hed.25568","volume":"41","author":"JS Bhangu","year":"2019","unstructured":"J.S. Bhangu, A. Selberherr, L. Brammen et al. Efficacy of calcium excretion and calcium\/creatinine clearance ratio in the differential diagnosis of familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Head Neck 41, 1372\u20131378 (2019). https:\/\/doi.org\/10.1002\/hed.25568","journal-title":"Head Neck"},{"key":"3560_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/cen.14254","volume":"93","author":"S Mariathasan","year":"2020","unstructured":"S. Mariathasan, K.A. Andrews, E. Thompson et al. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort. Clin. Endocrinol (Oxf) 93, 409\u2013418 (2020). https:\/\/doi.org\/10.1111\/cen.14254","journal-title":"Clin. Endocrinol (Oxf)"},{"key":"3560_CR13","doi-asserted-by":"publisher","unstructured":"Moore, E.C., Berber, E., Jin, J., et al. (2018) Calcium creatinine clearance ratio is not helpful in differentiating primary hyperparathyroidism from familial herpercalcemic hypocalciuria: A study of 1000 patients. Endocr. Pract. https:\/\/doi.org\/10.4158\/EP-2018-0350","DOI":"10.4158\/EP-2018-0350"},{"key":"3560_CR14","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"J.P. Bilezikian, A.A. Khan, S.J. Silverberg et al. Evaluation and management of primary hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J. Bone Miner Res. 37, 2293\u20132314 (2022). https:\/\/doi.org\/10.1002\/jbmr.4677","journal-title":"J. Bone Miner Res."},{"key":"3560_CR15","first-page":"115","volume":"132","author":"R Staden","year":"2000","unstructured":"R. Staden, K. Beal, J. Bonfield, The Staden package, 1998. Methods Mol. Biol. 132, 115\u2013130 (2000)","journal-title":"Methods Mol. Biol."},{"key":"3560_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nprot.2015.123","volume":"11","author":"R Vaser","year":"2016","unstructured":"R. Vaser, S. Adusumalli, S.N. Leng et al. SIFT missense predictions for genomes. Nat. Protoc. 11, 1\u20139 (2016)","journal-title":"Nat. Protoc."},{"key":"3560_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"I.A. Adzhubei, S. Schmidt, L. Peshkin et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248\u2013249 (2010)","journal-title":"Nat. Methods"},{"key":"3560_CR18","doi-asserted-by":"publisher","first-page":"e46688","DOI":"10.1371\/journal.pone.0046688","volume":"7","author":"Y Choi","year":"2012","unstructured":"Y. Choi, G.E. Sims, S. Murphy et al. Predicting the functional effect of aminoacid substitutions and indels. PLoS ONE 7, e46688 (2012)","journal-title":"PLoS ONE"},{"key":"3560_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"J.M. Schwarz, D.N. Cooper, M. Schuelke et al. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11, 361\u2013362 (2014)","journal-title":"Nat Methods"},{"key":"3560_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"S. Richards, N. Aziz, S. Bale et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17, 405\u2013424 (2015)","journal-title":"Genet Med."},{"key":"3560_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-physiol-021113-170336","volume":"76","author":"P Houillier","year":"2014","unstructured":"P. Houillier, Mechanisms and regulation of renal magnesium transport. Annu. Rev. Physiol. 76, 411\u2013430 (2014). https:\/\/doi.org\/10.1146\/annurev-physiol-021113-170336","journal-title":"Annu. Rev. Physiol."},{"key":"3560_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0002-9343(78)90814-8","volume":"65","author":"SJ Marx","year":"1978","unstructured":"S.J. Marx, A.M. Spiegel, E.M. Brown et al. Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am. J. Med. 65, 235\u2013242 (1978). https:\/\/doi.org\/10.1016\/0002-9343(78)90814-8","journal-title":"Am. J. Med."},{"key":"3560_CR23","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1210\/jc.2017-02773","volume":"103","author":"JP Bertocchio","year":"2018","unstructured":"J.P. Bertocchio, M. Tafflet, E. Koumakis et al. Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia. J. Clin. Endocrinol Metab. 103, 2534\u20132542 (2018). https:\/\/doi.org\/10.1210\/jc.2017-02773","journal-title":"J. Clin. Endocrinol Metab."},{"key":"3560_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/cen.14211","volume":"93","author":"C Mouly","year":"2020","unstructured":"C. Mouly, R. Vargas-Poussou, A. Lienhardt et al. Clinical characteristics of familial hypocalciuric hypercalcaemia type 1: A multicentre study of 77 adult patients. Clin. Endocrinol (Oxf) 93, 248\u2013260 (2020). https:\/\/doi.org\/10.1111\/cen.14211","journal-title":"Clin. Endocrinol (Oxf)"},{"key":"3560_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2265.2011.04059.x","volume":"75","author":"K Frank-Raue","year":"2011","unstructured":"K. Frank-Raue, G. Leidig-Bruckner, C. Haag et al. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism. Clin. Endocrinol (Oxf) 75, 50\u201355 (2011). https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04059.x","journal-title":"Clin. Endocrinol (Oxf)"},{"key":"3560_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","volume":"15","author":"FM Hannan","year":"2018","unstructured":"F.M. Hannan, E. Kallay, W. Chang et al. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat. Rev. Endocrinol 15, 33\u201351 (2018). https:\/\/doi.org\/10.1038\/s41574-018-0115-0","journal-title":"Nat. Rev. Endocrinol"},{"key":"3560_CR27","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1210\/jcem.80.11.7593455","volume":"80","author":"DB Thompson","year":"1995","unstructured":"D.B. Thompson, W.S. Samowitz, S. Odelberg et al. Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J. Clin. Endocrinol Metab. 80, 3377\u20133380 (1995). https:\/\/doi.org\/10.1210\/jcem.80.11.7593455","journal-title":"J. Clin. Endocrinol Metab."},{"key":"3560_CR28","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1210\/jcem.82.10.4300","volume":"82","author":"F Farnebo","year":"1997","unstructured":"F. Farnebo, U. Enberg, L. Grimelius et al. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J. Clin. Endocrinol Metab. 82, 3481\u20133486 (1997). https:\/\/doi.org\/10.1210\/jcem.82.10.4300","journal-title":"J. Clin. Endocrinol Metab."},{"key":"3560_CR29","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1210\/jcem.81.4.8636374","volume":"81","author":"O Kifor","year":"1996","unstructured":"O. Kifor, F.D. Moore Jr., P. Wang et al. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin. Endocrinol Metab. 81, 1598\u20131606 (1996). https:\/\/doi.org\/10.1210\/jcem.81.4.8636374","journal-title":"J Clin. Endocrinol Metab"},{"key":"3560_CR30","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1210\/jcem.85.12.7028","volume":"85","author":"F Cetani","year":"2000","unstructured":"F. Cetani, A. Picone, P. Cerrai et al. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism. J. Clin. Endocrinol Metab. 85, 4789\u20134794 (2000). https:\/\/doi.org\/10.1210\/jcem.85.12.7028","journal-title":"J. Clin. Endocrinol Metab."},{"key":"3560_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ki.1997.41","volume":"51","author":"J Gogusev","year":"1997","unstructured":"J. Gogusev, P. Duchambon, B. Hory et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int. 51, 328\u2013336 (1997). https:\/\/doi.org\/10.1038\/ki.1997.41","journal-title":"Kidney Int."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03560-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03560-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03560-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T02:17:37Z","timestamp":1709173057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03560-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["3560"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03560-y","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"7 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Institutional Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The study was granted informed consent waivers by the Ethics Committee since the identification of participants was not implemented.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}